Ono Pharmaceutical Co., Ltd. (4528) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shionogi & Co., Ltd.

Ono Pharmaceutical Co., Ltd.

Kyowa Kirin Co., Ltd.

Otsuka Holdings Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

Astellas Pharma, Inc.

Daiichi Sankyo Co., Ltd.

Kobayashi Pharmaceutical Co., Ltd.

Eisai Co., Ltd.

Takeda Pharmaceutical Co., Ltd.

Taisho Pharmaceutical Holdings Co., Ltd.

Why is Ono Pharmaceutical Co., Ltd. ?

High Management Efficiency with a high ROE of 12.49%

Company has very low debt and has enough cash to service the debt requirements

With a growth in Net Sales of 5.73%, the company declared Very Positive results in Mar 26

The company has declared positive results for the last 2 consecutive quarters
OPERATING CASH FLOW(Y) Highest at JPY 136,821 MM
PRE-TAX PROFIT(Q) At JPY 3,277 MM has Grown at 125.54%
DIVIDEND PAYOUT RATIO(Y) Highest at 2,297.79%

With ROE of 7.44%, it has a very attractive valuation with a 1.43 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 51.23%, its profits have fallen by -15.5%
At the current price, the company has a high dividend yield of 0

Majority shareholders : FIIs

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Ono Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Ono Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Ono Pharmaceutical Co., Ltd.

50.5%

0.14

26.36%

Japan Nikkei 225

81.96%

2.98

27.54%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.02%

EBIT Growth (5y)

-1.20%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.09

Sales to Capital Employed (avg)

0.56

Tax Ratio

15.48%

Dividend Payout Ratio

75.08%

Pledged Shares

Institutional Holding

0.04%

ROCE (avg)

20.45%

ROE (avg)

12.49%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.43

EV to EBIT

13.57

EV to EBITDA

9.40

EV to Capital Employed

1.47

EV to Sales

2.22

PEG Ratio

Dividend Yield

ROCE (Latest)

10.85%

ROE (Latest)

7.44%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

OPERATING CASH FLOW(Y)

Highest at JPY 136,821 MM

PRE-TAX PROFIT(Q)

At JPY 3,277 MM has Grown at 125.54%

DIVIDEND PAYOUT RATIO(Y)

Highest at 2,297.79%

RAW MATERIAL COST(Y)

Fallen by -21.19% (YoY

CASH AND EQV(HY)

Highest at JPY 427,943 MM

NET PROFIT(Q)

At JPY 818 MM has Grown at 112.5%

-4What is not working for the Company

INTEREST(Q)

At JPY 1,132 MM has Grown at 177.45%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.14 times

Here's what is working for Ono Pharmaceutical Co., Ltd.

Pre-Tax Profit

At JPY 3,277 MM has Grown at 125.54%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Operating Cash Flow

Highest at JPY 136,821 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (JPY MM)

Net Profit

At JPY 818 MM has Grown at 112.5%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

Cash and Eqv

Highest at JPY 427,943 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Dividend Payout Ratio

Highest at 2,297.79%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -21.19% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at JPY 9,607 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Ono Pharmaceutical Co., Ltd.

Interest

At JPY 1,132 MM has Grown at 177.45%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Inventory Turnover Ratio

Lowest at 2.14 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio